Summing up Skinive’s 2021 activities, we are excited to announce the list of events and conferences Skinive participated in during Autumn 2021: 1. The Next Web Conference (TNW)  (Sep 30 – Oct 01, 2021) TNW Conference is the most popular tech conference in Amsterdam, a 2-day technology event that brings together international technology executives, policymakers, […]

Skinive MD became available on Appstore and Google Play in May 2021. Over 3 months of summer, more than 3000 users from Europe took part in the open testing of the application and left Skinive reviews. Interesting fact: according to statistics, 8 out of 10 people make their choice based on reviews. Reviews also help […]

We are pleased to announce that Skinive has received CE Mark clearance in the European Union. The CE marking confirms that Skinive solutions meet the requirements of the European Medical Devices Directive (MDD). This clearance opens up the market significantly for our solutions. The CE mark covers 27 countries in the European Union. More importantly it […]

Skinive announces participation in the upcoming events: ⁃ IMCAS World Congress – the world leading congress in dermatology and plastic surgery Virtual Conference, Date: Jun 30, 2021IMCAS Congress brings together the latest evidence-based techniques from prominent speakers and the newest developments from major industry players. IMCAS Congresses are medical research conferences focused on providing plastic […]

We are pleased to announce that Skinive has become an information partner of DEBRA Russia, which is part of the international organization DEBRA International and provides comprehensive assistance to butterfly children diagnosed with epidermolysis bullosa (EB) in Russia and the CIS. We invite you to the DEBRA Annual International Congress 2021. The Congress will take […]

Consensus among experts confirms a glaring shortage of dermatologists, resulting in extended patient wait times, strained medical professionals, untreated ailments, and potential patients resorting to seeking treatment in distant cities. Given the gravity of this predicament, it becomes imperative for healthcare stakeholders to address two pivotal inquiries: What are the underlying causes of this challenge, […]